关注
Ulrike Binder
Ulrike Binder
Senior Scientist, Institute of Hygiene and Medical Microbiology,Medical University Innsbruck
在 i-med.ac.at 的电子邮件经过验证
标题
引用次数
引用次数
年份
Mucormycosis–from the pathogens to the disease
U Binder, E Maurer, C Lass‐Flörl
Clinical Microbiology and Infection 20, 60-66, 2014
2322014
The Penicillium chrysogenum antifungal protein PAF, a promising tool for the development of new antifungal therapies and fungal cell biology studies
F Marx, U Binder, E Leiter, I Pócsi
Cellular and Molecular Life Sciences 65, 445-454, 2008
1472008
Functional aspects of the solution structure and dynamics of PAF – a highly‐stable antifungal protein from Penicillium chrysogenum
G Batta, T Barna, Z Gaspari, S Sandor, KE Kövér, U Binder, B Sarg, ...
The FEBS journal 276 (10), 2875-2890, 2009
1122009
Fast-track development of an in vitro 3D lung/immune cell model to study Aspergillus infections
P Chandorkar, W Posch, V Zaderer, M Blatzer, M Steger, CG Ammann, ...
Scientific reports 7 (1), 11644, 2017
812017
Galleria mellonella: An invertebrate model to study pathogenicity in correctly defined fungal species
U Binder, E Maurer, C Lass-Flörl
Fungal Biology 120 (2), 288-295, 2016
802016
Galleria mellonella as a host model to study Aspergillus terreus virulence and amphotericin B resistance
E Maurer, N Browne, C Surlis, E Jukic, P Moser, K Kavanagh, C Lass-Flörl, ...
Virulence 6 (6), 591-598, 2015
802015
The antifungal activity of the Penicillium chrysogenum protein PAF disrupts calcium homeostasis in Neurospora crassa
U Binder, M Chu, ND Read, F Marx
Eukaryotic Cell 9 (9), 1374-1382, 2010
802010
Epidemiology of invasive fungal infections in the mediterranean area
U Binder, C Lass-Flörl
Mediterranean journal of hematology and infectious diseases 3 (1), 2011
752011
Galleria mellonella as a model system to study virulence potential of mucormycetes and evaluation of antifungal treatment
E Maurer, C Hörtnagl, M Lackner, D Grässle, V Naschberger, P Moser, ...
Medical mycology 57 (3), 351-362, 2019
702019
The metalloreductase FreB is involved in adaptation of Aspergillus fumigatus to iron starvation
M Blatzer, U Binder, H Haas
Fungal Genetics and Biology 48 (11), 1027-1033, 2011
672011
Antifungal drug testing by combining minimal inhibitory concentration testing with target identification by gas chromatography–mass spectrometry
C Müller, U Binder, F Bracher, M Giera
Nature Protocols 12 (5), 947-963, 2017
662017
The Aspergillus giganteus antifungal protein AFPNN5353activates the cell wall integrity pathway and perturbs calcium homeostasis
U Binder, M Bencina, A Eigentler, V Meyer, F Marx
BMC microbiology 11, 1-13, 2011
632011
Histidine biosynthesis plays a crucial role in metal homeostasis and virulence of Aspergillus fumigatus
AM Dietl, J Amich, S Leal, N Beckmann, U Binder, A Beilhack, E Pearlman, ...
Virulence 7 (4), 465-476, 2016
622016
The antifungal protein PAF interferes with PKC/MPK and cAMP/PKA signalling of Aspergillus nidulans
U Binder, C Oberparleiter, V Meyer, F Marx
Molecular microbiology 75 (2), 294-307, 2010
612010
Blocking Hsp70 enhances the efficiency of amphotericin B treatment against resistant Aspergillus terreus strains
M Blatzer, G Blum, E Jukic, W Posch, P Gruber, M Nagl, U Binder, ...
Antimicrobial agents and chemotherapy 59 (7), 3778-3788, 2015
602015
Oxidative stress response tips the balance in Aspergillus terreus amphotericin B resistance
E Jukic, M Blatzer, W Posch, M Steger, U Binder, C Lass-Flörl, ...
Antimicrobial Agents and Chemotherapy 61 (10), 10.1128/aac. 00670-17, 2017
492017
The Zn2Cys6-type transcription factor LeuB cross-links regulation of leucine biosynthesis and iron acquisition in Aspergillus fumigatus
N Long, T Orasch, S Zhang, L Gao, X Xu, P Hortschansky, J Ye, F Zhang, ...
PLoS Genetics 14 (10), e1007762, 2018
412018
Amphotericin B Resistance in Aspergillus terreus Is Overpowered by Coapplication of Pro-oxidants
M Blatzer, E Jukic, W Posch, B Schöpf, U Binder, M Steger, G Blum, ...
Antioxidants & redox signaling 23 (18), 1424-1438, 2015
392015
New insights into invasive aspergillosis-from the pathogen to the disease
U Binder, C Lass-Florl
Current pharmaceutical design 19 (20), 3679-3688, 2013
382013
Etest Cannot Be Recommended for In Vitro Susceptibility Testing of Mucorales
R Caramalho, E Maurer, U Binder, R Araújo, S Dolatabadi, C Lass-Flörl, ...
Antimicrobial Agents and Chemotherapy 59 (6), 3663-3665, 2015
362015
系统目前无法执行此操作,请稍后再试。
文章 1–20